Press release
Nuclear Medicine/Radiopharmaceuticals Industry worth $9.4 billion by 2028, with a CAGR of 11.3%
Nuclear Medicine Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology, Thyroid, Oncology), Procedures, End User - Global Forecast to 2028
The nuclear medicine industry is poised for significant growth in the near future, driven by the increasing incidence of cancer and chronic diseases that require advanced diagnostic and treatment options. Advancements in imaging technology, such as hybrid imaging and PET-CT scans, are also fueling demand for nuclear medicine. Additionally, there is a focus on developing radiopharmaceuticals and theragnostic that can target specific diseases and deliver treatments directly to affected areas. Despite potential challenges such as the high cost of equipment and the shortage of trained professionals, the outlook for the nuclear medicine industry is positive, and it is expected to continue to innovate and improve patient care in the coming years.
Nuclear Medicine Market [https://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $5.5 billion in 2023 and is poised to reach $9.4 billion by 2028, growing at a CAGR of 11.3% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . The nuclear medicine market is mainly driven by factors such as rising incidence and prevalence of target disease and need for adoption of nuclear medicine for early diagnosis of diseases. However, hospital budget cuts and high equipment prices have made it difficult for a section of end users to opt for nuclear medicine are challenging the growth of this market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=417 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=417&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse in-depth TOC on "Nuclear Medicine Market"
449 - Tables39 - Figures359 - Pages
Nuclear Medicine Market Scope:
Report Coverage
Details
Market Revenue in 2023
$5.5 billion
Estimated Value by 2028
$9.4 billion
Growth Rate
Poised to grow at a CAGR of 11.3%
Market Size Available for
2021-2028
Forecast Period
2023-2028
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
By Type, Application, Procedure volume, End User & Region
Geographies Covered
North America, Europe, Asia Pacific, ROW
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Use of radiopharmaceuticals in neurological applications
Key Market Drivers
Increasing incidence and prevalence of target conditions
The diagnostic nuclear medicine segment is expected to hold the largest market share during the forecast period.
On the basis of type, the nuclear medicine market is segmented into diagnostic and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is further categorized as SPECT and PET radiopharmaceuticals, while the therapeutic nuclear medicine segment is further divided into beta emitters, alpha emitters, and brachytherapy isotopes. The diagnostic nuclear medicine segment is expected to holds the largest share of the nuclear medicine market during forecast period. The rising prevalence of cancer and cardiovascular diseases, and advancements in radiotracers are some of the key factors driving the growth of this segment.
The diagnostic procedure segment is projected to hold the largest market share during the forecast period.
On the basis of procedural volume, the nuclear medicine market is segmented into diagnostic and therapeutic procedures. The diagnostic procedure segment is further categorized as SPECT and PET procedures. The diagnostic procedures accounted for the largest share, in the nuclear medicine market. The large share of this segment can be attributed to the diagnostic radioisotopes finding wider demand and use as compared to therapeutic radioisotopes.
The diagnostic application segment is expected to account for the largest share of the nuclear medicine application market in 2022.
On the basis of application, the nuclear medicine market is segmented into diagnostic and therapeutic applications. The diagnostic application segment is further categorized as SPECT and PET applications, while the therapeutic nuclear medicine segment is further divided into endocrine tumors, thyroid indications, bone metastasis, lymphoma, other therapeutic applications. The diagnostic application segment is expected to account for the largest share of the nuclear medicine market. The increasing demand for SPECT diagnosis owing to the rising demand for minimally invasive surgeries and targeted radiotherapy is the major factor driving the adoption of the diagnostic application using nuclear medicine.
North America accounted for the largest share for players operating in the nuclear medicine market in 2022
On the basis of region, the nuclear medicine market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America holds the largest share of the nuclear medicine market in 2022. This can be attributed to the rising surge of geriatric population, growing requirement of nuclear medicine in the early diagnosis of diseases, technology advancement for radioisotope production, government funding, and key players in this region are also impelling the nuclear medicine market in the region.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=417 [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=417&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Nuclear Medicine Market Dynamics:
Drivers:
* Increasing incidence and prevalence of target conditions
* Development of alpha-radioimmunotherapy-based targeted cancer treatments
* Initiatives to reduce demand and supply gap of Mo-99
Restraints:
* Short half-life of radiopharmaceuticals
Opportunities:
* Use of radiopharmaceuticals in neurological applications
* Growth opportunities in emerging economies
Challenges:
* Hospital budget cuts and high equipment costs
Key Market Players:
The nuclear medicine market is highly consolidated. Some of the major players operating in this market include GE HealthCare (US), Cardinal Health (US), Curium (France),Bayer AG (Germany), Lantheus Holdings, Inc.(US), Bracco Imaging S.p.A. (Italy), PharmaLogic Holdings Corp. (US), Eczacibasi-Monrol Nuclear Products (Turkey), NTP Radioisotopes SOC Ltd (South Africa), Nordion Inc.(Canada), Advanced Accelerator Applications (France), NorthStar Medical Radioisotopes (US), Eckert & Ziegler (Germany), Isotope JSC (Russia), Siemens Healthineers (Germany), Jubilant DraxImage,Inc. (Canada).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=417 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=417&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nuclear-medicineradiopharmaceuticals-industry-worth-94-billion-by-2028-with-a-cagr-of-113]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nuclear Medicine/Radiopharmaceuticals Industry worth $9.4 billion by 2028, with a CAGR of 11.3% here
News-ID: 4178012 • Views: …
More Releases from ABNewswire
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others.
DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,…
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Obser …
The Key Asthma Companies in the market inlcude - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Regeneron Pharmaceuticals, RAPT Therapeutics, Inc., Incyte Corporation, Areteia Therapeutics, Suzhou Connect Biopharmaceuticals, Ltd., Cumberland Pharmaceuticals, Pulmatrix Inc., and others.
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and…
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through …
The Key Inflammatory Bowel Disease Companies: AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma, RedHill Biopharma, Tryp Therapeutics, Eli Lilly and Company, Gilead, Galapagos, Applied Molecular Transport, Protagonist Therapeutics, Janssen, AstraZeneca, Vifor Pharma, Astellas Pharma, Shield Therapeutics, Takeda, Ocera Therapeutics, Sanofi, Morphic Therapeutic, Inc., Bausch Health Americas, Inc., Qu Biologics Inc., Vifor Pharma, and others
DelveInsight's "Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
Celebrate Vince Guaraldi During The Record Store Day National Listening Party We …
This fall, music lovers across the nation are invited to drop the needle, turn up the volume, and celebrate the magic of vinyl during Record Store Day's National Listening Party Weekend, taking place October 17-19, 2025. Over 200 independent record stores nationwide will host exclusive listening events, bringing together collectors, audiophiles, and fans for a weekend devoted to timeless music and community connection.
At the heart of this year's celebration is…
More Releases for Nuclear
Nuclear Energy Market is Going to Boom : GE Hitachi Nuclear Energy, China Nation …
HTF MI introduces new research on Nuclear Energy covering the micro level of analysis by competitors and key business segments (2023-2029). The Nuclear Energy explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing.
Some of the major key players profiled…
Nuclear Technology Market Is Booming Worldwide | Areva, Foro Nuclear, Emirates N …
Advance Market Analytics published a new research publication on "Nuclear Technology Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Nuclear Technology market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Nuclear Reactor Market - Crucial business trends 2025 | FirstEnergy Nuclear Gene …
Global Nuclear Reactor Market: Snapshot
The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’…
Nuclear Reactor Market - Promising growth opportunities 2025 | FirstEnergy Nucle …
Global Nuclear Reactor Market: Snapshot
The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’…
Nuclear Energy Industry Analysis of Nuclear Fuels Market 2017-2021
Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate electricity.
. .
– Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1069449
' '
Global nuclear fuels market to grow…
UAE Nuclear Power Sector UAE Nuclear Power Sales Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. UAE Power Sector Scenario
1.1 Existing Power Generation Outlook
1.2 Current & Projected Power Demand
2. Why UAE Energy Policy beyond Oil & Gas?
3. UAE Nuclear Power Sector Overview
3.1 UAE Entering into Nuclear Power Sector
3.2 Nuclear Policy Overview
4. UAE Nuclear Power Sector Dynamics
4.1 Favorable Parameters
4.2 Nuclear Power Sector…
